Milestone Scientific (MLSS) vs Myomo (MYO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Myomo (MYO) has outperformed Milestone Scientific (MLSS) over the past year, gaining 23.3% versus a loss of 35.2%. Over five years, MLSS leads with a -83.4% price change compared with -89.3% for MYO. Myomo is the larger company by market cap ($56.6 million vs $31.7 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLSS | MYO |
|---|---|---|
| Share price | $0.35 | $1.43 |
| Market cap | $31.71M | $56.64M |
| 1-day change | -2.78% | +1.42% |
| YTD return | +29.63% | +57.14% |
| 1-year return | -35.19% | +23.28% |
| 5-year return | -83.41% | -89.28% |
| EPS (TTM) | $-0.04 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.58 | $1.89 |
| 52-week low | $0.22 | $0.605 |
| Distance from 52-week high | -39.66% | -24.14% |
| Analyst consensus | none | none |
| Avg. price target upside | +257.14% | +224.48% |
| Average volume | 127.62K | 496.01K |
| Shares outstanding | 90.61M | 39.61M |
| Employees | 15 | 194 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MYO has outperformed MLSS by 58.5 percentage points over the past year.
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Health Care · Industrial Specialties · 15 employees
About Myomo
MYO stock →Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Health Care · Industrial Specialties · 194 employees
MLSS vs MYO FAQ
Which is bigger, Milestone Scientific or Myomo?
Myomo (MYO) is larger, with a market capitalization of $56.64M compared with $31.71M for Milestone Scientific (MLSS).
Which stock has performed better over the past year, MLSS or MYO?
MYO returned +23.28% over the past 12 months, compared with -35.19% for MLSS (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Scientific and Myomo in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.